Engineering Change Order / Notice
Documents that authorize and communicate changes to released designs, BOMs, or manufacturing processes.
Definition
ECO/ECN processes are the practical mechanism behind the 21 CFR 820.30(i) and ISO 13485 §7.3.9 design change requirements. They link the change request to impact analysis, approvals, training, and effectivity. A typical change process covers the request, impact assessment on design, risk, validation and regulatory status, approvals by a change board, and an effective date. Regulatory review decides whether a change needs a new 510(k), a PMA supplement or notified body notification. FDA guidance on deciding when to submit a 510(k) for a change is a common reference.What this means in practice
PLM systems automate ECO routing; weak effectivity tracking leads to mixed-revision inventory and field issues.Examples
- An ECO is initiated to update the firmware of an infusion pump to fix a software bug identified during post-market surveillance, requiring re-validation and regulatory submission.
- An ECN is raised to change a material supplier for a critical component of a surgical instrument, necessitating a re-evaluation of biocompatibility and performance.
- A manufacturer uses an ECO to implement a minor aesthetic change to a device’s packaging, which still requires documented approval but may not trigger extensive re-testing.
- •Failing to assess the full impact of a change across all relevant product documentation, manufacturing processes, and supplier agreements is a common pitfall.
- •Implementing a change without adequate verification or validation can lead to product non-conformities and patient safety issues.
- •Not involving all necessary stakeholders, such as regulatory, quality, R&D, and manufacturing teams, in the ECO/ECN process can result in overlooked requirements or implementation challenges.
- •Poor control over effectivity dates can result in mixed inventory, making it difficult to trace which product versions are in the field and comply with specific change implementations.
- •Treating minor changes with the same rigorous process as major ones, or conversely, not giving sufficient attention to cumulative minor changes, can bottleneck operations or introduce uncontrolled risk.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Manufacturing
· Same categoryStructured list of every component, sub-assembly, and quantity needed to manufacture a device.
Quantification of viable microorganisms on or in a product before sterilization.
ISO 14644 classification of cleanrooms by airborne particulate cleanliness (ISO 1 through ISO 9).
Demonstration that a sterile package maintains microbial barrier and contents integrity over the labeled shelf life.
Where this term appears across MedTech Terms.
Sources
3 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 121 CFR 820.30(i)Tier 1 VerifiedeCFRecfr.gov
- 2FDA - Device ManufacturingTier 2 VerifiedFDAfda.gov
- 3ISO 13485 Standard PageTier 1 VerifiedISOiso.org
Inline markers like [1] jump to the matching reference above.